These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 25754492)

  • 1. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
    Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones.
    Nosova EV; Lipunova GN; Charushin VN; Chupakhin ON
    Mini Rev Med Chem; 2019; 19(12):999-1014. PubMed ID: 30324881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.
    Guo S; Fu L; Wang B; Chen X; Zhao J; Liu M; Lu Y
    Biomed Pharmacother; 2020 Nov; 131():110777. PubMed ID: 33152936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
    Penta A; Franzblau S; Wan B; Murugesan S
    Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
    Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
    Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
    Patel KN; Telvekar VN
    Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
    Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
    Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
    Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis.
    Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Ma C; Wang D; Wang A; Qin X; Liu M; Lu Y
    Eur J Med Chem; 2021 Jun; 218():113398. PubMed ID: 33823392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
    Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
    Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
    Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a new combination therapy for tuberculosis with next generation benzothiazinones.
    Makarov V; Lechartier B; Zhang M; Neres J; van der Sar AM; Raadsen SA; Hartkoorn RC; Ryabova OB; Vocat A; Decosterd LA; Widmer N; Buclin T; Bitter W; Andries K; Pojer F; Dyson PJ; Cole ST
    EMBO Mol Med; 2014 Mar; 6(3):372-83. PubMed ID: 24500695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies.
    Reddy DS; Hosamani KM; Devarajegowda HC
    Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
    Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.